Aeterna Zentaris to Present at Upcoming Rodman Renshaw Annual Global
Investment Conference on September 14
QUÉBEC CITY, Sept. 7 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at the upcoming Rodman Renshaw Annual Global Investment Conference on Tuesday, September 14, 2010, at 12:05 p.m. ET, in the Hubbard Salon (5th floor) of the New York Palace Hotel, in New York City.
A live webcast of the presentation will be available on Aeterna Zentaris' website at www.aezsinc.com in the Newsroom section. A replay will also be available for a period of 30 days on the Company's website.
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.
For further information: Investor Relations: Ginette Vallières, Investor Relations Coordinator, (418) 652-8525 ext. 265, [email protected]; Media Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406, [email protected]
Share this article